Filing Details

Accession Number:
0001410939-22-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-22 16:43:18
Reporting Period:
2022-03-18
Accepted Time:
2022-03-22 16:43:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Iveric Bio Inc. ISEE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277478 Glenn Sblendorio C/O Iveric Bio, Inc.
8 Sylvan Way
Parsippany NJ 07054
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-18 3,479 $2.94 283,168 No 4 M Direct
Common Stock Disposition 2022-03-18 3,479 $17.00 279,689 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-03-18 3,479 $0.00 3,479 $2.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
387,144 2027-12-18 No 4 M Direct
Footnotes
  1. The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021.
  2. This total includes 556 shares acquired by the Reporting Person on March 15, 2022, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
  3. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $17.00 to $17.01 per share on March 18, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
  4. This stock option award was granted on December 19, 2017 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.